Neuberger Berman Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240K Buy
+11,215
New +$233K ﹤0.01% 1933
2025
Q3
Sell
-14,730
Closed -$211K 2108
2025
Q2
$211K Buy
14,730
+1,373
+10% +$18.8K ﹤0.01% 1875
2025
Q1
$194K Sell
13,357
-193
-1% -$2.74K ﹤0.01% 1822
2024
Q4
$178K Buy
13,550
+448
+3% +$6.18K ﹤0.01% 1809
2024
Q3
$152K Sell
13,102
-1,904
-13% -$18K ﹤0.01% 1820
2024
Q2
$113K Buy
15,006
+60
+0.4% +$496 ﹤0.01% 1806
2024
Q1
$150K Sell
14,946
-595
-4% -$5.54K ﹤0.01% 1768
2023
Q4
$145K Buy
15,541
+1,002
+7% +$10.4K ﹤0.01% 1781
2023
Q3
$185K Sell
14,539
-2,202
-13% -$30.2K ﹤0.01% 1706
2023
Q2
$238K Sell
16,741
-30,456
-65% -$428K ﹤0.01% 1659
2023
Q1
$704K Buy
47,197
+7,919
+20% +$120K ﹤0.01% 1354
2022
Q4
$584K Sell
39,278
-5,072
-11% -$82.8K ﹤0.01% 1399
2022
Q3
$732K Sell
44,350
-917
-2% -$18.5K ﹤0.01% 1356
2022
Q2
$951K Sell
45,267
-588
-1% -$12K ﹤0.01% 1295
2022
Q1
$1.08M Sell
45,855
-3,504
-7% -$85.8K ﹤0.01% 1331
2021
Q4
$1.21M Sell
49,359
-238,864
-83% -$6.39M ﹤0.01% 1308
2021
Q3
$7.97M Sell
288,223
-115,309
-29% -$3.51M 0.01% 860
2021
Q2
$11.9M Sell
403,532
-745,292
-65% -$22M 0.01% 791
2021
Q1
$29.1M Sell
1,148,824
-428,821
-27% -$11M 0.03% 586
2020
Q4
$38.6M Buy
1,577,645
+277,366
+21% +$5.21M 0.04% 467
2020
Q3
$21.2M Sell
1,300,279
-35,946
-3% -$669K 0.03% 570
2020
Q2
$22.8M Sell
1,336,225
-3,704
-0.3% -$54.9K 0.03% 536
2020
Q1
$15.6M Sell
1,339,929
-6,405
-0.5% -$132K 0.02% 554
2019
Q4
$37.4M Sell
1,346,334
-3,252
-0.2% -$81.5K 0.04% 455
2019
Q3
$30.5M Buy
1,349,586
+657,015
+95% +$15M 0.04% 479
2019
Q2
$17.5M Buy
692,571
+280,034
+68% +$7.52M 0.02% 633
2019
Q1
$11.2M Buy
+412,537
New +$13.8M 0.01% 716
2018
Q2
Sell
-102,037
Closed -$5.68M 1731
2018
Q1
$5.68M Hold
102,037
0.01% 869
2017
Q4
$5.45M Buy
+102,037
New +$4.81M 0.01% 868
2017
Q3
Sell
-5,522
Closed -$333K 1628
2017
Q2
$333K Buy
5,522
+13
+0.2% +$771 ﹤0.01% 1389
2017
Q1
$382K Sell
5,509
-328
-6% -$22.8K ﹤0.01% 1360
2016
Q4
$389K Sell
5,837
-3,530
-38% -$230K ﹤0.01% 1349
2016
Q3
$621K Sell
9,367
-173
-2% -$11.8K ﹤0.01% 1219
2016
Q2
$691K Buy
9,540
+3,077
+48% +$212K ﹤0.01% 1176
2016
Q1
$418K Sell
6,463
-2,028
-24% -$135K ﹤0.01% 1303
2015
Q4
$608K Buy
8,491
+2,224
+35% +$164K ﹤0.01% 1225
2015
Q3
$481K Sell
6,267
-610
-9% -$49.2K ﹤0.01% 1287
2015
Q2
$510K Sell
6,877
-1,747
-20% -$126K ﹤0.01% 1321
2015
Q1
$625K Sell
8,624
-459
-5% -$31.9K ﹤0.01% 1298
2014
Q4
$600K Sell
9,083
-1,973
-18% -$120K ﹤0.01% 1317
2014
Q3
$606K Sell
11,056
-1,824
-14% -$103K ﹤0.01% 1335
2014
Q2
$749K Sell
12,880
-3,057
-19% -$180K ﹤0.01% 1310
2014
Q1
$987K Sell
15,937
-42
-0.3% -$2.44K ﹤0.01% 1221
2013
Q4
$853K Buy
15,979
+655
+4% +$35.2K ﹤0.01% 1239
2013
Q3
$769K Sell
15,324
-3,192
-17% -$156K ﹤0.01% 1228
2013
Q2
$848K Buy
+18,516
New +$829K ﹤0.01% 1215

Other funds holding MD

Neuberger Berman Group's MD Position: Q1 2026 in Review

Neuberger Berman Group opened a new position in Pediatrix Medical (MD) in Q1 2026: 11,215 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #1933 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in MD as recently as Q2 2025.

Neuberger Berman Group first reported a position in MD in Q2 2013 and has held it in 46 quarters since. The position peaked at $38.6M in Q4 2020. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Neuberger Berman Group held 11,215 shares of Pediatrix Medical worth $240K as of Q1 2026.
  • Pediatrix Medical was a new Neuberger Berman Group position in Q1 2026.
  • Pediatrix Medical made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1933 holding.
  • Neuberger Berman Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 46 quarters since.
  • Neuberger Berman Group's Pediatrix Medical position peaked at $38.6M in Q4 2020.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.